Uploaded April 2026 | Updated September 2026, 3 days ago
What does the future hold for anti-obesity medications?
In this episode from EASD TV, experts Dr. Daniela Liśkiewicz and Dr. Juan Pablo Frías explore the next generation of obesity treatments: from GLP-1–based therapies and oral medications to multi-target and highly personalised approaches.
The discussion goes beyond weight loss, focusing on long-term health, weight maintenance, and the importance of combining pharmacotherapy with lifestyle change.
Topics covered include cover, the evolution of GLP-1 therapies and oral alternatives, multi-agonist and combination treatments, the importance of preserving muscle mass during weight loss, challenges in maintaining weight loss after treatment, new biological targets, including metabolic set-point regulation, the role of prevention and global access to therapies.
Listen now and subscribe to keep up-to-date with new content!
What does the future hold for anti-obesity medications?
In this episode from EASD TV, experts Dr. Daniela Liśkiewicz and Dr. Juan Pablo Frías explore the next generation of obesity treatments: from GLP-1–based therapies and oral medications to multi-target and highly personalised approaches.
The discussion goes beyond weight loss, focusing on long-term health, weight maintenance, and the importance of combining pharmacotherapy with lifestyle change.
Topics covered include cover, the evolution of GLP-1 therapies and oral alternatives, multi-agonist and combination treatments, the importance of preserving muscle mass during weight loss, challenges in maintaining weight loss after treatment, new biological targets, including metabolic set-point regulation, the role of prevention and global access to therapies.
Listen now and subscribe to keep up-to-date with new content!
